Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP273240IR

Pancreatic Amylase Beta Antibody (OTI4B5), DyLight 755, Novus Biologicals™
SDP

Catalog No. NBP273240IR Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP273240IR 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP273240IR Supplier Novus Biologicals Supplier No. NBP273240IR
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Pancreatic Amylase Beta Monoclonal specifically detects Pancreatic Amylase Beta in Human, Mouse samples. It is validated for Western Blot, Immunohistochemistry.

Specifications

Antigen Pancreatic Amylase Beta
Applications Western Blot, Immunohistochemistry
Classification Monoclonal
Clone OTI4B5
Conjugate DyLight 755
Dilution Western Blot, Immunohistochemistry
Formulation 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias alpha-amylase 2B, AMY2, AMY2B amylase, alpha 2B (pancreatic)
Gene Symbols AMY2B
Host Species Mouse
Immunogen Full length recombinant protein of human Pancreatic Amylase Beta (NP_066188) produced in HEK293T cells.
Purification Method Affinity Purified
Quantity 0.1 mL
Primary or Secondary Primary
Gene ID (Entrez) 280.0
Target Species Human, Mouse
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.